Systemic treatment of malignant pleural effusion

D. W. Geiger, U. J. Haffner, V. Haas, S. Decker, J. R. Fischer (Löwenstein, Germany)

Source: Annual Congress 2005 - What's new in the pleura
Session: What's new in the pleura
Session type: Oral Presentation
Number: 4475
Disease area: Thoracic oncology

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. W. Geiger, U. J. Haffner, V. Haas, S. Decker, J. R. Fischer (Löwenstein, Germany). Systemic treatment of malignant pleural effusion. Eur Respir J 2005; 26: Suppl. 49, 4475

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients
Source: Eur Respir J 2011; 38: 1425-1430
Year: 2011



An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Pleural effusion in lung cancer and targeted therapy
Source: Hands-on Course 2013 - Medical Thoracoscopy
Year: 2013

Management of malignant pleural effusion in recurrent SCLC by intrapleural gene therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 61s
Year: 2003

Videothoracoscopy in the treatment of malignant pleural effusions
Source: Annual Congress 2009 - Pleural and mediastinal diseases
Year: 2009

Survival of lung adenocarcinoma patients with malignant pleural effusion
Source: Eur Respir J 2013; 41: 1409-1418
Year: 2013



Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions
Source: Eur Respir J 2004; 24: 263-266
Year: 2004



Pleurodesis in the treatment of malignant pleural effusion
Source: Eur Respir J 2004; 24: Suppl. 48, 628s
Year: 2004

Malignant pleural mesothelioma: new treatment modalities
Source: Annual Congress 2005 - Clinical year in review
Year: 2005

Malignant pleural effusion - diagnosis and treatment
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017

Malignant pleural disease in primary lung cancer
Source: Eur Respir Mon; 2009: 44: 318–335
Year: 2009

Systemic therapy 1 in malignant pleural mesothelioma: chemotherapy
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Malignant pericardial effusion in lung cancer patients
Source: Annual Congress 2006 - Treatment and complications of treatment of lung cancer and malignant pleural effusions
Year: 2006

Evaluation of concomitant pleural effusions in patients with lung cancers
Source: Eur Respir J 2007; 30: Suppl. 51, 668s
Year: 2007

Chemotherapy for treatment of malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Results of treatment of the metastatic pleural effusion
Source: Annual Congress 2012 - Clinical issues in malignant pleural effusions
Year: 2012

Systemic treatment of malignant mesothelioma
Source: Eur Respir Mon; 2009: 44: 419–434
Year: 2009

Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017